These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 23726541)

  • 1. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
    Hansen RN; Nguyen HP; Sullivan SD
    Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between antiepileptic drug switching and epilepsy-related events.
    Hansen RN; Campbell JD; Sullivan SD
    Epilepsy Behav; 2009 Aug; 15(4):481-5. PubMed ID: 19615948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs.
    Devine ST; Weisbart E; Barron J; Behm A
    Curr Med Res Opin; 2010 Feb; 26(2):455-63. PubMed ID: 20014974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
    Kesselheim AS; Bykov K; Gagne JJ; Wang SV; Choudhry NK
    Neurology; 2016 Oct; 87(17):1796-1801. PubMed ID: 27683844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
    Zachry WM; Doan QD; Clewell JD; Smith BJ
    Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.
    Shcherbakova N; Rascati K; Brown C; Lawson K; Novak S; Richards KM; Yoder L
    CNS Drugs; 2014 Nov; 28(11):1047-58. PubMed ID: 25086640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
    Rascati KL; Richards KM; Johnsrud MT; Mann TA
    Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refilling and switching of antiepileptic drugs and seizure-related events.
    Gagne JJ; Avorn J; Shrank WH; Schneeweiss S
    Clin Pharmacol Ther; 2010 Sep; 88(3):347-53. PubMed ID: 20631693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F; Duh MS; Gosselin A; Paradis PE
    Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis.
    Faught E; Helmers S; Thurman D; Kim H; Kalilani L
    Epilepsy Behav; 2018 Aug; 85():37-44. PubMed ID: 29906700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
    Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
    Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptic drug use and epileptic seizures in elderly nursing home residents: a survey in the province of Pavia, Northern Italy.
    Galimberti CA; Magri F; Magnani B; Arbasino C; Cravello L; Marchioni E; Tartara A
    Epilepsy Res; 2006 Jan; 68(1):1-8. PubMed ID: 16330188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study.
    Handoko KB; Zwart-van Rijkom JE; Hermens WA; Souverein PC; Egberts TC
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):189-96. PubMed ID: 17036373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy.
    Manjunath R; Davis KL; Candrilli SD; Ettinger AB
    Epilepsy Behav; 2009 Feb; 14(2):372-8. PubMed ID: 19126436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment in patients with newly diagnosed unprovoked seizures/epilepsy.
    Karlsson L; Wettermark B; Tomson T
    Epilepsy Res; 2014 Jul; 108(5):902-8. PubMed ID: 24721202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
    Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
    Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL; Candrilli SD; Edin HM
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in pill appearance of antiepileptic drugs and the risk of nonadherence.
    Kesselheim AS; Misono AS; Shrank WH; Greene JA; Doherty M; Avorn J; Choudhry NK
    JAMA Intern Med; 2013 Feb; 173(3):202-8. PubMed ID: 23277164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.